Back

Results - Announcements

Sales rise 26.51% to Rs 708.46 crore

Marksans Pharma consolidated net profit rises 15.66% in the March 2025 quarter

20-May-2025, 07:46
Net profit of Marksans Pharma rose 15.66% to Rs 90.55 crore in the quarter ended March 2025 as against Rs 78.29 crore during the previous quarter ended March 2024. Sales rose 26.51% to Rs 708.46 crore in the quarter ended March 2025 as against Rs 560.01 crore during the previous quarter ended March 2024.

For the full year,net profit rose 21.32% to Rs 380.58 crore in the year ended March 2025 as against Rs 313.70 crore during the previous year ended March 2024. Sales rose 20.46% to Rs 2622.85 crore in the year ended March 2025 as against Rs 2177.41 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	708.46	560.01	27	2622.85	2177.41	20
OPM %	17.75	19.58	-	20.15	21.06	-
PBDT	138.84	121.33	14	587.35	497.80	18
PBT	116.09	100.28	16	503.97	423.53	19
NP	90.55	78.29	16	380.58	313.70	21